Journal Home
Search for

Volume 89, Issue 1, Pages 22-34 (January 2007)


View previous. 4 of 49 View next.

Prefrontal cortex and insight in schizophrenia: A volumetric MRI study

Adegboyega Saparaa, Michael Cookea, Dominic Fannonb, Alan Francisc, Robert W. Buchananc, Anantha P.P. Anilkumarb, Ian Barkatakib, Ingrid Aasenab, Elizabeth Kuipersa, Veena KumariaCorresponding Author Informationemail address

Received 10 April 2006; received in revised form 20 September 2006; accepted 24 September 2006. published online 15 November 2006.

Abstract 

Previous studies have suggested a relationship between frontal lobe-based neuropsychological functions and insight in schizophrenia. There is some evidence linking both smaller whole brain volume and frontal cortical atrophy to poor insight in this population. We investigated the relationship between total as well as specific prefrontal regional volumes and insight in schizophrenia. Twenty-eight stable outpatients with schizophrenia underwent magnetic resonance imaging scanning and assessment for insight. Insight was measured using the Birchwood self-report Insight Scale and the Expanded Schedule of Assessment of Insight. The whole brain and prefrontal regional (superior frontal, middle frontal, inferior frontal and orbitofrontal) volumes were then manually measured using the Cavalieri method and established criteria. Twenty healthy subjects were also scanned to provide control data for volumetric assessments. Smaller total prefrontal grey matter volume was moderately associated with a lower level of insight into the presence of illness. At the prefrontal sub-regional level, volumes of the superior, inferior and orbitofrontal regions contributed to this relationship, especially in males. It is concluded that smaller prefrontal grey matter volume is associated with poor insight into the presence of illness in stable schizophrenia patients. Future research should examine the association of specific dimensions of insight with frontal as well as non-frontal regional brain volumes.

a King's College London, Institute of Psychiatry, Department of Psychology, London, UK

b King's College London, Institute of Psychiatry, Division of Psychological Medicine, Section of General Psychiatry, London, UK

c Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, USA

Corresponding Author InformationCorresponding author. PO78, Institute of Psychiatry, De Crespigny Park, London SE5 8AF, UK. Tel.: +44 207 848 0233; fax: +44 207 708 0860.

PII: S0920-9964(06)00413-0

doi:10.1016/j.schres.2006.09.016


View previous. 4 of 49 View next.